Assembly Bill 747 aims to regulate the sale of hemp-derived cannabinoid products in Wisconsin by establishing specific definitions, requirements, and restrictions. The bill modifies the current definition of hemp to include hemp-derived cannabinoid products and specifies that the testing criteria for hemp must utilize high-performance liquid chromatography, gas chromatography-mass spectrometry, or other reliable methods. It introduces a new definition for hemp-derived cannabinoids and products, which includes various forms of THC, and outlines that these products cannot be sold to individuals under 21 years of age.

Additionally, the bill mandates that manufacturers must submit samples of their products to accredited laboratories for testing before sale, ensuring that the products meet safety and labeling standards. The products must include a certificate of analysis, which can be provided via a QR code, and must be labeled with detailed information about the manufacturer, cannabinoid content, and safety warnings. The bill also prohibits the sale of hemp-derived cannabinoid products in non-child-resistant packaging and sets limits on THC content in beverages. Overall, the legislation seeks to enhance consumer safety and regulate the market for hemp-derived cannabinoid products effectively.

Statutes affected:
Bill Text: 94.55(1), 94.55